Selected research
Market Structure
Global Vasopressin V1b Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Vasopressin V1b Receptor market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Vasopressin V1b Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Vasopressin V1b Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Vasopressin V1b Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Vasopressin V1b Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Vasopressin V1b Receptor include Allergan Plc, AbbVie Inc., Orphan Therapeutics, LLC, Laboratorio ELEA S.A.C.I.F. y A. and Azevan Pharmaceuticals, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Vasopressin V1b Receptor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Vasopressin V1b Receptor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Vasopressin V1b Receptor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vasopressin V1b Receptor market size, projected growth trends, production technologies, key applications, and end-use industries.
Vasopressin V1b Receptor Segment by Company
Allergan Plc
AbbVie Inc.
Orphan Therapeutics, LLC
Laboratorio ELEA S.A.C.I.F. y A.
Azevan Pharmaceuticals, Inc.
Vasopressin V1b Receptor Segment by Type
ABT-436
AVN-628
PHT-103
Others
Vasopressin V1b Receptor Segment by Application
Hospital
Clinic
Others
Vasopressin V1b Receptor Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vasopressin V1b Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vasopressin V1b Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vasopressin V1b Receptor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Vasopressin V1b Receptor market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vasopressin V1b Receptor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vasopressin V1b Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Vasopressin V1b Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- ABT-436
- AVN-628
- PHT-103
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Allergan Plc
- AbbVie Inc.
- Orphan Therapeutics, LLC
- Laboratorio ELEA S.A.C.I.F. y A.
- Azevan Pharmaceuticals, Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Vasopressin V1b Receptor Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Vasopressin V1b Receptor Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Vasopressin V1b Receptor Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Vasopressin V1b Receptor Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Vasopressin V1b Receptor Market Dynamics
- 2.1 Vasopressin V1b Receptor Industry Trends
- 2.2 Vasopressin V1b Receptor Industry Drivers
- 2.3 Vasopressin V1b Receptor Industry Opportunities and Challenges
- 2.4 Vasopressin V1b Receptor Industry Restraints
3 Vasopressin V1b Receptor Market by Manufacturers
- 3.1 Global Vasopressin V1b Receptor Revenue by Manufacturers (2021-2026)
- 3.2 Global Vasopressin V1b Receptor Sales by Manufacturers (2021-2026)
- 3.3 Global Vasopressin V1b Receptor Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Vasopressin V1b Receptor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Vasopressin V1b Receptor Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Vasopressin V1b Receptor Manufacturers, Product Type & Application
- 3.7 Global Vasopressin V1b Receptor Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Vasopressin V1b Receptor Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Vasopressin V1b Receptor Players Market Share by Revenue in 2025
- 3.8.3 2025 Vasopressin V1b Receptor Tier 1, Tier 2, and Tier 3
4 Vasopressin V1b Receptor Market by Type
- 4.1 Vasopressin V1b Receptor Type Introduction
- 4.1.1 ABT-436
- 4.1.2 AVN-628
- 4.1.3 PHT-103
- 4.1.4 Others
- 4.2 Global Vasopressin V1b Receptor Sales by Type
- 4.2.1 Global Vasopressin V1b Receptor Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Vasopressin V1b Receptor Sales by Type (2021-2032)
- 4.2.3 Global Vasopressin V1b Receptor Sales Market Share by Type (2021-2032)
- 4.3 Global Vasopressin V1b Receptor Revenue by Type
- 4.3.1 Global Vasopressin V1b Receptor Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Vasopressin V1b Receptor Revenue by Type (2021-2032)
- 4.3.3 Global Vasopressin V1b Receptor Revenue Market Share by Type (2021-2032)
5 Vasopressin V1b Receptor Market by Application
- 5.1 Vasopressin V1b Receptor Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Vasopressin V1b Receptor Sales by Application
- 5.2.1 Global Vasopressin V1b Receptor Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Vasopressin V1b Receptor Sales by Application (2021-2032)
- 5.2.3 Global Vasopressin V1b Receptor Sales Market Share by Application (2021-2032)
- 5.3 Global Vasopressin V1b Receptor Revenue by Application
- 5.3.1 Global Vasopressin V1b Receptor Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Vasopressin V1b Receptor Revenue by Application (2021-2032)
- 5.3.3 Global Vasopressin V1b Receptor Revenue Market Share by Application (2021-2032)
6 Global Vasopressin V1b Receptor Sales by Region
- 6.1 Global Vasopressin V1b Receptor Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Vasopressin V1b Receptor Sales by Region (2021-2032)
- 6.2.1 Global Vasopressin V1b Receptor Sales by Region (2021-2026)
- 6.2.2 Global Vasopressin V1b Receptor Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Vasopressin V1b Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Vasopressin V1b Receptor Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Vasopressin V1b Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Vasopressin V1b Receptor Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Vasopressin V1b Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Vasopressin V1b Receptor Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Vasopressin V1b Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Vasopressin V1b Receptor Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Vasopressin V1b Receptor Revenue by Region
- 7.1 Global Vasopressin V1b Receptor Revenue by Region
- 7.1.1 Global Vasopressin V1b Receptor Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Vasopressin V1b Receptor Revenue by Region (2021-2026)
- 7.1.3 Global Vasopressin V1b Receptor Revenue by Region (2027-2032)
- 7.1.4 Global Vasopressin V1b Receptor Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Vasopressin V1b Receptor Revenue (2021-2032)
- 7.2.2 North America Vasopressin V1b Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Vasopressin V1b Receptor Revenue (2021-2032)
- 7.3.2 Europe Vasopressin V1b Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Vasopressin V1b Receptor Revenue (2021-2032)
- 7.4.2 Asia-Pacific Vasopressin V1b Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Vasopressin V1b Receptor Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Vasopressin V1b Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Allergan Plc
- 8.1.1 Allergan Plc Company Information
- 8.1.2 Allergan Plc Business Overview
- 8.1.3 Allergan Plc Vasopressin V1b Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Allergan Plc Vasopressin V1b Receptor Product Portfolio
- 8.1.5 Allergan Plc Recent Developments
- 8.2 AbbVie Inc.
- 8.2.1 AbbVie Inc. Company Information
- 8.2.2 AbbVie Inc. Business Overview
- 8.2.3 AbbVie Inc. Vasopressin V1b Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 AbbVie Inc. Vasopressin V1b Receptor Product Portfolio
- 8.2.5 AbbVie Inc. Recent Developments
- 8.3 Orphan Therapeutics, LLC
- 8.3.1 Orphan Therapeutics, LLC Company Information
- 8.3.2 Orphan Therapeutics, LLC Business Overview
- 8.3.3 Orphan Therapeutics, LLC Vasopressin V1b Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Orphan Therapeutics, LLC Vasopressin V1b Receptor Product Portfolio
- 8.3.5 Orphan Therapeutics, LLC Recent Developments
- 8.4 Laboratorio ELEA S.A.C.I.F. y A.
- 8.4.1 Laboratorio ELEA S.A.C.I.F. y A. Company Information
- 8.4.2 Laboratorio ELEA S.A.C.I.F. y A. Business Overview
- 8.4.3 Laboratorio ELEA S.A.C.I.F. y A. Vasopressin V1b Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Laboratorio ELEA S.A.C.I.F. y A. Vasopressin V1b Receptor Product Portfolio
- 8.4.5 Laboratorio ELEA S.A.C.I.F. y A. Recent Developments
- 8.5 Azevan Pharmaceuticals, Inc.
- 8.5.1 Azevan Pharmaceuticals, Inc. Company Information
- 8.5.2 Azevan Pharmaceuticals, Inc. Business Overview
- 8.5.3 Azevan Pharmaceuticals, Inc. Vasopressin V1b Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Azevan Pharmaceuticals, Inc. Vasopressin V1b Receptor Product Portfolio
- 8.5.5 Azevan Pharmaceuticals, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Vasopressin V1b Receptor Value Chain Analysis
- 9.1.1 Vasopressin V1b Receptor Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Vasopressin V1b Receptor Production Mode & Process
- 9.2 Vasopressin V1b Receptor Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Vasopressin V1b Receptor Distributors
- 9.2.3 Vasopressin V1b Receptor Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst